← Back to Search

Discontinue statin for Cardiovascular Disease

Phase 4
Waitlist Available
Led By Julia Schneider
Research Sponsored by Loyola University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change in mobility at 12 weeks
Awards & highlights

Study Summary

Patients who are on chronic dialysis and 70 and older are frequently on multiple medications including statins. However, the benefit of statins in dialysis patient population is uncertain. Several randomized trials showed no benefit of statins on mortality in dialysis patient population. Guidelines recommend not starting statins in patients on dialysis who are not already taking them. However, there are no guidelines on what to do in patients who are already taking statins. The investigators are doing a short pilot study to discontinue statin in our dialysis patient population and evaluating the effects on discontinuation of statins on quality of life, cognition, as physical strength.

Eligible Conditions
  • Cardiovascular Disease
  • Renal Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change in frailty at 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and change in frailty at 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in quality of life
Secondary outcome measures
Change in handgrip strength
Other outcome measures
Change in cognition
Change in frailty
Change in mobility

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Discontinue statinExperimental Treatment1 Intervention
Patients randomized to this group will stop using the statins they are currently prescribed and will not use their statin medication for 12 weeks.
Group II: Usual careActive Control1 Intervention
These patients will continue as statins as usual.

Find a Location

Who is running the clinical trial?

Loyola UniversityLead Sponsor
156 Previous Clinical Trials
30,904 Total Patients Enrolled
Julia SchneiderPrincipal InvestigatorLoyola University Chicago

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Kidney InternationalJournal
KDIGO Clinical Practice Guideline for Lipid Management in CKD: Summary of Recommendation Statements and Clinical Approach to the Patient
Wanner, Christoph, the Kidney Disease: Improving Global Outcomes Lipid Guideline Development Work Group Members, and Marcello Tonelli. 2014. “KDIGO Clinical Practice Guideline for Lipid Management in CKD: Summary of Recommendation Statements and Clinical Approach to the Patient”. Kidney International. Elsevier BV. doi:10.1038/ki.2014.31.
clinicaltrials.govStudy
The Impact of Statin Holiday in Dialysis Patients Over 70 Years Old on Mental Function, Physical Function and Frailty
Julia Schneider 2018. "The Impact of Statin Holiday in Dialysis Patients Over 70 Years Old on Mental Function, Physical Function and Frailty". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03663049.
All > Dialysis
~4 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top